Form 4 Filing for Aquestive Therapeutics, Inc.

Peter E. Boyd, Chief People Officer of Aquestive Therapeutics, Inc., exercised a Common Stock Purchase Warrant on September 9, 2026. The warrant, acquired on June 8, 2022, had an exercise price of $0.96 per share. Boyd exercised 2,293 warrants, disposing of them and acquiring 2,293 shares of Common Stock. Post-transaction, Boyd holds 284,024 shares of Common Stock. This transaction is classified under officer-director-10 percent owner transactions.